Clinical Trials

Study Title

Pragmatic Randomized Trial of Proton Vs. Photon Therapy for Patients with Non-Metastatic Breast Cancer: a Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial

Purpose

A pragmatic randomized clinical trial of patients with locally advanced breast cancer randomized to either proton or photon therapy and followed longitudinally for cardiovascular morbidity and mortality, health-related quality of life, and cancer control outcomes. Quality of life is the outcome measure for the estimated primary completion date of December, 2024, www.radcomp.org.

For more information please visit: https://clinicaltrials.gov/study/NCT02603341

Interested in Volunteering for the Study?
If you would like more information about this study, please call us at (318) 212-8671.

Eligibility

Study Process